Literature DB >> 12665652

Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.

Bing Xu1, Toshiaki Sano, Katsuhiko Yoshimoto, Shozo Yamada.   

Abstract

The cadherin-catenin complex regulates cellular adhesion and motility, and genetic alterations in these molecules play a critical role in multistage tumorigenesis. In this study, the expression of three major type I classic cadherins E-, N-, and P-cadherin and their undercoat proteins alpha-, beta-, and gamma-catenin, and pp120 was investigated in 127 pituitary adenomas and 10 normal adenohypophyseal glands using an immunohistochemical technique with highly specific monoclonal antibodies. In normal pituitary glands, E-cadherin, catenins, and pp120 were strongly expressed on almost all hormone-producing cell-cell boundaries, N-cadherin was weakly immunoreactive on a few cell-cell boundaries, and P-cadherin was negative. In pituitary adenomas, a correlation was not identified among expression of E-cadherin, catenins, or pp120 with patient age, sex, hormone level, tumor size, and/or invasiveness, respectively. Expression of E-cadherin, catenins, and pp120 was significantly reduced in 24 growth hormone (GH) cell adenomas with prominent fibrous bodies compared with the other subtypes of pituitary adenomas and normal pituitary glands (p < 0.0001, respectively). Methylation-specific polymerase chain reaction analysis revealed that the E-cadherin gene promoter region was methylated in 6 of 16 (37.5%) GH cell adenomas with prominent fibrous bodies examined, 2 of which displayed total methylation, but not in 10 GH cell adenomas without fibrous bodies. No mutation of exon 3 of the beta-catenin gene was found in 16 GH cell adenomas with prominent fibrous bodies or in 10 other subtypes of pituitary adenomas that showed unremarkable intracellular presence of beta-catenin protein. In conclusion, the decreased expression of the E-cadherin catenin complex and methylation of the E-cadherin gene promoter region only in GH cell adenomas with prominent fibrous bodies may be an event associated with the formation of fibrous bodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12665652     DOI: 10.1385/ep:13:4:341

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  39 in total

Review 1.  Cytoskeletal proteins connecting intermediate filaments to cytoplasmic and nuclear periphery.

Authors:  K Djabali
Journal:  Histol Histopathol       Date:  1999-04       Impact factor: 2.303

Review 2.  E-cadherin-catenin cell-cell adhesion complex and human cancer.

Authors:  B P Wijnhoven; W N Dinjens; M Pignatelli
Journal:  Br J Surg       Date:  2000-08       Impact factor: 6.939

3.  Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.

Authors:  A Valizadeh; A J Karayiannakis; I el-Hariry; W Kmiot; M Pignatelli
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children.

Authors:  J E Haas; N F Palmer; A G Weinberg; J B Beckwith
Journal:  Hum Pathol       Date:  1981-07       Impact factor: 3.466

5.  Frequent nuclear accumulation of beta-catenin in pituitary adenoma.

Authors:  S Semba; S Y Han; H Ikeda; A Horii
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

Review 6.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Nuclear Accumulation of B-Catenin in Human Endocrine Tumors: Association with Ki-67 (MIB-1) Proliferative Activity.

Authors:  Shuho Semba; Ryoko Kusumi; Takuya Moriya; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

8.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

Authors:  B Rubinfeld; I Albert; E Porfiri; C Fiol; S Munemitsu; P Polakis
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

10.  Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis.

Authors:  Y Hirai; A Nose; S Kobayashi; M Takeichi
Journal:  Development       Date:  1989-02       Impact factor: 6.868

View more
  18 in total

Review 1.  Clinical implications of growth hormone-secreting tumor subtypes.

Authors:  Katja Kiseljak-Vassiliades; Shibana Shafi; Janice M Kerr; Tzu L Phang; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Endocrine       Date:  2012-03-21       Impact factor: 3.633

Review 2.  Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.

Authors:  Luis V Syro; Fabio Rotondo; Carlos A Serna; Leon D Ortiz; Kalman Kovacs
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.

Authors:  Katja Kiseljak-Vassiliades; Mei Xu; Taylor S Mills; Elizabeth E Smith; Lori J Silveira; Kevin O Lillehei; Janice M Kerr; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Mol Cell Endocrinol       Date:  2015-09-21       Impact factor: 4.102

4.  Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.

Authors:  Cheng-Chia Lee; Mary Lee Vance; M Beatriz Lopes; Zhiyuan Xu; Ching-Jen Chen; Jason Sheehan
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

5.  Elucidating the Role of the Desmosome Protein p53 Apoptosis Effector Related to PMP-22 in Growth Hormone Tumors.

Authors:  Katja Kiseljak-Vassiliades; Taylor S Mills; Yu Zhang; Mei Xu; Kevin O Lillehei; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

6.  Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas.

Authors:  Yifan Tang; Tao Xie; Silin Wu; Qiaoqiao Yang; Tengfei Liu; Chen Li; Shuang Liu; Zhiyong Shao; Xiaobiao Zhang
Journal:  Endocrine       Date:  2021-05-27       Impact factor: 3.633

7.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.

Authors:  Yasushi Tanaka; Toshiaki Sano; Zhi Rong Qian; Mitsuyoshi Hirokawa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

8.  Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.

Authors:  Johan Arild Evang; Jens Bollerslev; Olivera Casar-Borota; Tove Lekva; Jon Ramm-Pettersen; Jens Petter Berg
Journal:  Endocrine       Date:  2013-01-13       Impact factor: 3.633

9.  Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Authors:  Abdulkader Obari; Toshiaki Sano; Kenichi Ohyama; Eiji Kudo; Zhi Rong Qian; Akiko Yoneda; Nasim Rayhan; Muhammad Mustafizur Rahman; Shozo Yamada
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 10.  Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.

Authors:  Maria Gueorguiev; Ashley B Grossman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.